Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.

New UK research reveals that combining weight loss injections with coaching and regular tracking can lead to 53% more ...

"We recommend that any patients experiencing side effects while taking GLP-1 receptor agonists including Wegovy® (semaglutide ...

How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal ...

A popular weight-loss drug may be changing how doctors treat obesity—but scientists are just starting to uncover exactly how ...

Signs and symptoms of low ... (except for switching to non-study tirzepatide or semaglutide). This estimand assumes that participants who had weight loss procedures during the study did not ...

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy ...

Primary care physicians aren’t quick to diagnose lymphedema in patients with obesity, a situation that needs to change, ...